Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-11-05
2011-10-11
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C436S518000
Reexamination Certificate
active
08034573
ABSTRACT:
Provided are methods of determining whether a cell in a tissue site is viable or nonviable. Also provided are methods of debriding tissue from a tissue site. Further provided are kits comprising a compound that distinguishes between viable and nonviable cells and instructions for using the compound on a tissue site. Additionally, the use of a compound that distinguishes between viable and nonviable cells is provided, where the use is to determine whether a cell in a tissue site is viable or nonviable. Also provided is a use of a compound that distinguishes between viable and nonviable cells, where the use is for the manufacture of the above-described kit.
REFERENCES:
patent: 5178884 (1993-01-01), Goodrich et al.
patent: 5497770 (1996-03-01), Morcos et al.
patent: 6057096 (2000-05-01), Rothschild et al.
patent: 6174291 (2001-01-01), McMahon et al.
patent: 6482802 (2002-11-01), Hu et al.
patent: 6927049 (2005-08-01), Rubinsky et al.
patent: 7052854 (2006-05-01), Melker et al.
patent: 7149567 (2006-12-01), Demos et al.
patent: 7276255 (2007-10-01), Selkon
patent: 7366365 (2008-04-01), Carver
patent: 7553624 (2009-06-01), Nagai et al.
patent: 2003/0068663 (2003-04-01), Huang et al.
patent: 2004/0234523 (2004-11-01), Dinarello et al.
patent: 2005/0004453 (2005-01-01), Tearney et al.
patent: 2005/0171414 (2005-08-01), Demos et al.
patent: 2005/0245492 (2005-11-01), Lephart et al.
patent: 2006/0205646 (2006-09-01), Sanders et al.
patent: 2007/0024946 (2007-02-01), Panasyuk et al.
patent: 2007/0038121 (2007-02-01), Feldman et al.
patent: 2007/0127789 (2007-06-01), Hoppel et al.
patent: 2007/0197895 (2007-08-01), Nycz
patent: 2007/0218457 (2007-09-01), McKim
patent: 2007/0243521 (2007-10-01), Zuckerman
patent: 2008/0192248 (2008-08-01), Carver
patent: WO 91/12766 (1991-09-01), None
patent: WO 96/08201 (1996-03-01), None
patent: WO 2007/069040 (2007-06-01), None
patent: WO2007/130423 (2007-11-01), None
Yang et al. (Biomaterials 2002, vol. 23, p. 1391-1397).
Plovins et al. (Applied Environ. Microbiology 1994, vol. 60, p. 4638-4641).
Knight et al. Euro J Pharmacology 1997 vol. 332, p. 273-278.
Barrie, K.A., Steinmann, S.P., Shin, A.Y., Spinner, R.J., and Bishop, A.T. Gracilis free muscle transfer for restoration of function after complete brachial plexus avulsion. Neurosurg. Focus 16, 2004. p. E8.
Jackson, D.M., The diagnosis of the depth of burning. Br J Surg. 40, 1953. p. 588-596.
Molnar, J.A. MD, PhD, FACS, Jordan L. Simpson, BS, Denise M. Voignier, CMA, Michael J. Morykwas, PhD, and Louis C. Argenta, MD, Management of an Acute Thermal Injury With Subatmospheric Pressure, J Burns Wounds 4, 2005. p. e5.
International Search Report and Written Opinion date mailed Feb. 13, 2009; PCT Application No. PCT/US2008/082499.
E.N. Brody and L, Gold, “Aptamers as Therapeutic and Diagnostic Agents,” Reviews in Molecular Biotechnology 74 (2000) 5-13.
M. Bustin, “At the Crossroads of Necrosis and Apoptosis: Signaling to Multiple Cellular Targets by HMGB1,” Sci. STKE 2006 (151), pe39, Sep. 24, 2002.
L-M. Gerland, et al., “Association of Increased Autophagic Inclusions Labeled for β-Galactosidase with Fibroblastic Aging,” Experimental Gerontology 38 (2003), 887-895.
E. Jabloski and T. Adams, “The Merging of Nucleic Acid Detection and Immunoassays,” IVD Technology, Nov./Dec. 2006, pp. 63-70.
M. Mir, et al., “Aptamer Biosensors: An Alternative to Immunosensors,” IVD Technology, May 2007, pp. 39-47.
D. Parekh, “Laparoscopic-Assisted Pancreatic Necrosectomy,” Arch. Surg./vol. 141, Sep. 2006, pp. 895-903.
P. Scaffidi, et al., “Release of Chromatin Protein HMGB1 by Necrotic Cells Triggers Inflammation,” Nature vol. 418, Jul. 11, 2002, pp. 191-195.
L. Schaefer, et al., “Biglycan, a Nitric Oxide-Regulated Gene, Affects Adhesion, Growth, and Survival of Mesangial Cells,” The Journal of Biological Chemistry, vol. 278, No. 28, Issue of Jul. 11, pp. 26227-26237, 2003.
B.H. Schneider, et al. “Hartman Interferometer: Versatile Integrated Optic Sensor for Label-Free, Real-Time Quantification of Nucleic Acids, Proteins and Pathogens,” Clinical Chemistry 43:9, 1997, pp. 1757-1763.
J. Seal, et al., “Point-of-Care Nucleic Acid Lateral-Flow Tests,” IVD Technology, 12(9), 2006, pp. 41-51.
M. Todorović, “In vivo Burn Imaging Using Mueller Optical Coherence Tomography,” Jul. 7, 2008; vol. 16, No. 14; Optics Express, pp. 10279-10284.
M. Analoui and D. Dunn, “Optical Methods in Drug Discovery and Development”, Optical Methods in Drug Discovery and Development, Proceedings of the SPIE, vol. 6009, (2005); No Abstract Available.
F. Van Herreweghe, et al., “Tumor Necrosis Factor-Induced Modulation of Glyoxalase I Activities Through Phosphorylation by PKA Results in Cell Death and is Accompanied by the Formation of a Specific Methylglyoxal-Derived AGE,” Proc. Natl. Acad. Sci. USA 99,2002, pp. 949-954.
Brem, “Molecular Markers in Patients with Chronic Wounds to Guide Surgical Debridement,” Mol. Med. 13 (1-2) pp. 30-39, Jan.-Feb. 2007.
C. Sun, et al., “Tumor-Targeted Drug Delivery and MRI Contrast Enhancement by Chlorotoxin-Conjugated Iron Oxide Nanoparticles,” Nanomedicine 2008 3(4), pp. 495-505.
C. Sun, et al.“In Vivo MRI Detection of Gliomas by Chlorotoxin-Conjugated Superparamagnetic Nanoprobes,” small 2008, 4, No. 3, pp. 372-379.
M. Veiseh, “Tumor Paint: A Chlorotoxin: Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci,” Cancer Res 2007; 67: (14), Jul. 15, 2007, pp. 6882-6888.
Xiaobing F et al: “Special Spectacles Facilitating Debridement: A Report of Their Use in 300 Cases.” Injury 1992, LNKD-PUBMET: 1541509, vol. 23, No. 1, pp. 64-66, XP26241029, ISSN: 0020-1383, the year is 1992 (so obvious!!??) The source is from “Injury” journal.
Fruchterman Todd
Kieswetter Kristine
McNulty Amy
Cheu Jacob
KCI Licensing Inc.
LandOfFree
Identification of tissue for debridement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification of tissue for debridement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of tissue for debridement will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4273599